SEC Form 4 · accession 0001209191-15-027480
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Halley E Gilbert
Officer — Chief Legal Officer
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Mar 16, 2015 | A | 28,750 | $0.00 | A | 37,611 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $15.62 | Mar 16, 2015 | A | 57,500 | A | — | Mar 16, 2025 | Class A Common Stock | 57,500 | 57,500 | D |
Explanation of responses
- F1The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
- F2The reporting person acquired a total of 1,932 shares of Class A Common Stock under the issuer's employee stock purchase plan in the following transactions: 1,476 shares acquired on June 30, 2014 and 456 shares acquired on December 31, 2014.
- F3The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2015.